Leadless Pacemaker

Udo EO, Zuithoff NP, van Hemel NM, de Cock CC, Hendriks T, Doevendans PA, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm 2012;9:728-35.

Tobin K, Stewart J, Westveer D, Frumin H. Acute complications of permanent pacemaker implantation: their financial implication and relation to volume and operator experience. Am J Cardiol 2000;85:774-6, A9.

Cantillon DJ, Exner DV, Badie N, Davis K, Gu NY, Nabutovsky Y, et al. Complications and Health Care Costs Associated With Transvenous Cardiac Pacemakers in a Nationwide Assessment. JACC Clin Electrophysiol 2017;3:1296-305.

Cantillon DJ, Dukkipati SR, Ip JH, Exner DV, Niazi IK, Banker RS, et al. Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers. Heart Rhythm 2018;15:1023-30.

Wang Y, Hou W, Zhou C, Yin Y, Lu S, Liu G, et al. Meta-analysis of the incidence of lead dislodgement with conventional and leadless pacemaker systems. Pacing Clin Electrophysiol 2018;41:1365-71.

Reddy VY, Exner DV, Cantillon DJ, Doshi R, Bunch TJ, Tomassoni GF, et al. Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. N Engl J Med 2015;373:1125-35.

Knops RE, Tjong FV, Neuzil P, Sperzel J, Miller MA, Petru J, et al. Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial. J Am Coll Cardiol 2015;65:1497-504.

Reddy VY, Knops RE, Sperzel J, Miller MA, Petru J, Simon J, et al. Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation 2014;129:1466-71.

Lakkireddy D, Knops R, Atwater B, Neuzil P, Ip J, Gonzalez E, et al. A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker. Heart Rhythm 2017;14:1756-63.

Reddy VY, Exner DV, Doshi R, Tomassoni G, Bunch TJ, Estes NAM, et al. Primary Results on Safety and Efficacy From the LEADLESS II-Phase 2 Worldwide Clinical Trial. JACC Clin Electrophysiol 2022;8:115-7.

Reynolds D, Duray GZ, Omar R, Soejima K, Neuzil P, Zhang S, et al. A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med 2016;374:533-41.

Duray GZ, Ritter P, El-Chami M, Narasimhan C, Omar R, Tolosana JM, et al. Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. Heart Rhythm 2017;14:702-9.

El-Chami MF, Al-Samadi F, Clementy N, Garweg C, Martinez-Sande JL, Piccini JP, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control. Heart Rhythm 2018;15:1800-7.

Roberts PR, Clementy N, Al Samadi F, Garweg C, Martinez-Sande JL, Iacopino S, et al. A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm 2017;14:1375-9.

El-Chami MF, Soejima K, Piccini JP, Reynolds D, Ritter P, Okabe T, et al. Incidence and outcomes of systemic infections in patients with leadless pacemakers: Data from the Micra IDE study. Pacing Clin Electrophysiol 2019;42:1105-10.

El-Chami MF, Bonner M, Holbrook R, Stromberg K, Mayotte J, Molan A, et al. Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms. Heart Rhythm 2020;17:1393-7.

Dar T, Akella K, Murtaza G, Sharma S, Afzal MR, Gopinathannair R, et al. Comparison of the safety and efficacy of Nanostim and Micra transcatheter leadless pacemaker (LP) extractions: a multicenter experience. J Interv Card Electrophysiol 2020;57:133-40.

Li J, Hou WB, Cao MK, Zhou WX, Wang Y, Fang Y, et al. Safety and efficacy of leadless pacemaker retrieval. J Cardiovasc Electrophysiol 2019;30:1671-8.

Bhatia NK, Kiani S, Merchant FM, Delurgio DB, Patel AM, Leon AR, et al. Life cycle management of Micra transcatheter pacing system: Data from a high-volume center. J Cardiovasc Electrophysiol 2021;32:484-90.

Hauser RG, Hayes DL, Kallinen LM, Cannom DS, Epstein AE, Almquist AK, et al. Clinical experience with pacemaker pulse generators and transvenous leads: an 8-year prospective multicenter study. Heart Rhythm 2007;4:154-60.

Loring Z, North R, Hellkamp AS, Atwater BD, Frazier-Mills CG, Jackson KP, et al. VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers. Pacing Clin Electrophysiol 2020;43:1461-6.

Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2021;42:3427-520.

Hala P, Neuzil P, Keller J, Moucka P, Mudroch M, Dujka L, et al. Quantification of artifacts during cardiac magnetic resonance in patients with leadless Micra pacemakers. J Cardiovasc Electrophysiol 2021;32:1367-75.

Kiblboeck D, Reiter C, Kammler J, Schmit P, Blessberger H, Kellermair J, et al. Artefacts in 1.5 Tesla and 3 Tesla cardiovascular magnetic resonance imaging in patients with leadless cardiac pacemakers. J Cardiovasc Magn Reson 2018;20:47.

Kruse I, Arnman K, Conradson TB, Ryden L. A comparison of the acute and long-term hemodynamic effects of ventricular inhibited and atrial synchronous ventricular inhibited pacing. Circulation 1982;65:846-55.

Chinitz L, Ritter P, Khelae SK, Iacopino S, Garweg C, Grazia-Bongiorni M, et al. Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: Results from the Micra atrioventricular feasibility studies. Heart Rhythm 2018;15:1363-71.

Steinwender C, Khelae SK, Garweg C, Chan JYS, Ritter P, Johansen JB, et al. Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker: Results From the MARVEL 2 Study. JACC Clin Electrophysiol 2020;6:94-106.

Bereuter L, Gysin M, Kueffer T, Kucera M, Niederhauser T, Fuhrer J, et al. Leadless Dual-Chamber Pacing: A Novel Communication Method for Wireless Pacemaker Synchronization. JACC Basic Transl Sci 2018;3:813-23.

Vatterott PJ, Eggen MD, Hilpisch KE, Drake RA, Grubac V, Anderson TA, et al. Implant, performance, and retrieval of an atrial leadless pacemaker in sheep. Heart Rhythm 2021;18:288-96.

Knops RE, Olde Nordkamp LRA, Delnoy PHM, Boersma LVA, Kuschyk J, El-Chami MF, et al. Subcutaneous or Transvenous Defibrillator Therapy. N Engl J Med 2020;383:526-36.

Tjong FVY, Brouwer TF, Koop B, Soltis B, Shuros A, Schmidt B, et al. Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator. JACC Clin Electrophysiol 2017;3:1487-98.

Tjong FV, Brouwer TF, Smeding L, Kooiman KM, de Groot JR, Ligon D, et al. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance. Europace 2016;18:1740-7.

Breeman KTN, Swackhamer B, Brisben AJ, Quast ABE, Carter N, Shuros A, et al. Long-term performance of a novel communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: A comprehensive preclinical study. Heart Rhythm 2022;19:837-46.

Fernandez-Palacios G, Garcia-Moran E, Sandin-Fuentes M, Garcia-Granja PE, Rubio J, San Roman AJ. The utility of a combined synchronous atrioventricular leadless pacemaker and subcutaneous implantable cardiac defibrillator system in bilateral upper limb venous occlusion. Europace 2021;23:814.

Wijesuriya N, Elliott MK, Mehta V, Sidhu BS, Strocchi M, Behar JM, et al. Leadless Left Bundle Branch Area Pacing in Cardiac Resynchronisation Therapy: Advances, Challenges and Future Directions. Front Physiol 2022;13:898866.

Auricchio A, Delnoy PP, Butter C, Brachmann J, Van Erven L, Spitzer S, et al. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study. Europace 2014;16:681-8.

Reddy VY, Miller MA, Neuzil P, Sogaard P, Butter C, Seifert M, et al. Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing: The SELECT-LV Study. J Am Coll Cardiol 2017;69:2119-29.

Sieniewicz BJ, Betts TR, James S, Turley A, Butter C, Seifert M, et al. Real-world experience of leadless left ventricular endocardial cardiac resynchronization therapy: A multicenter international registry of the WiSE-CRT pacing system. Heart Rhythm 2020;17:1291-7.

Wijesuriya N, Elliott MK, Mehta V, Sidhu BS, Behar JM, Niederer S, et al. Leadless left ventricular endocardial pacing for cardiac resynchronization therapy: A systematic review and meta-analysis. Heart Rhythm 2022;19:1176-83.

Okabe T, Hummel JD, Bank AJ, Niazi IK, McGrew FA, Kindsvater S, et al. Leadless left ventricular stimulation with WiSE-CRT System - Initial experience and results from phase I of SOLVE-CRT Study (nonrandomized, roll-in phase). Heart Rhythm 2022;19:22-9.

Carabelli A, Jabeur M, Jacon P, Rinaldi CA, Leclercq C, Rovaris G, et al. European experience with a first totally leadless cardiac resynchronization therapy pacemaker system. Europace 2021;23:740-7.

Sidhu BS, Gould J, Porter B, Elliott M, Mehta V, Niederer S, et al. Completely Leadless Cardiac Resynchronization Defibrillator System. JACC Clin Electrophysiol 2020;6:588-9.

Elliott MK, Sidhu BS, Mehta VS, Gould J, Martic D, Rinaldi CA. The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems. HeartRhythm Case Rep 2021;7:628-32.

Teigeler T, Kolominsky J, Vo C, Shepard RK, Kalahasty G, Kron J, et al. Intermediate-term performance and safety of His-bundle pacing leads: A single-center experience. Heart Rhythm 2021;18:743-9.

Padala SK, Ellenbogen KA. Left bundle branch pacing is the best approach to physiological pacing. Heart Rhythm O2 2020;1:59-67.